Natriuretic peptides in patients with atrial fibrillation

Cardiology Journal

Volumn 15, Issue 6, 2008, Pages 525-529

  Wozakowska Kapłon, Beata ^a,d   Opolski, Grzegorz ^b   Herman, Zbigniew ^c   Kosior, Dariusz ^b  

^a KIELCE UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d wi torzyskie Centrum Kardiologii   (Poland)

Author keywords

Artrial fibrillation; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; DISEASE CLASSIFICATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; PROGNOSIS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; STROKE VOLUME;

EID: 59849087990     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides. Clin Chem, 2004; 50: 33-50.
2. Struthers AD. Natriuretic peptides in congestive heart failure - more than just markers. In: Coats A ed. Controversies in the management of heart failure. Churchill Livingstone, Edinburgh 1997: 133-146.
3. Wozakowska-Kaplon B, Opolski G. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: A clinical, echocardiographic and hormonal study. Int J Cardiol, 2004; 96: 171-176.
4. Wozakowska-Kaplon B. Effects of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol, 2004; 93: 1555-1558.
5. De Bold AJ. Origin and determinants of ANF and BNP production by the heart under normal and pathophysiological conditions. 2006; ISHNE Heart Failure World Wide Internet Symposium (http://www.hf-symposium.org/ lectures/ing_debold_adolfo_1.php).
6. Boomama F, Van der Meiracker AH. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res, 2001; 51: 442-449.
7. Cantin M, Thibault G, Haile-Meskel H. Atrial natriuretic factor in the impulse conduction system of rat cardiac ventricles. Cell Tiss Res, 1989; 256: 309-325.
8. Wozakowska-Kaplon B, Opolski G. Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol, 2003; 41: 1716-1720.
9. Wozakowska-Kaplon B, Opolski G, Kosior D, Janion M. An increase in plasma atrial natriuretic peptide concentration during exercise predicts a successful cardioversion and maintenance of sinus rhythm in patients with chronic atrial fibrillation. PACE, 2000; 23: 1876-1879.
10. Wozakowska-Kaplon B, Opolski G, Janion M, Kosior DA. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure. Kardiol Pol, 2004; 61: 513-517.
11. Rossi A, Enriquez-Sarano M, Burnett JC Jr, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation. A prospective hormonal and Doppler - echocardiographic study. J Am Coll Cardiol, 2000; 35: 1256-1262.
12. Ohta Y, Shimada T, Yoshitomi H et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol, 2001; 17: 415-420.
13. Jourdain P, Bellorini M, Funck F et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: A hormonal study. Eur J Heart Fail, 2002; 4: 263-267.
14. Ellinor PT, Low AF, Patton KK, Shea MA, MacRac CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol, 2005; 45: 82-86.
15. Wang TJ, Larson MG, Levy D et al. Plasma natriuretic peptide levels at risk of cardiovascular events and death. N Engl J Med, 2004; 350: 655-663.